Concepedia

Publication | Open Access

Multiple‐dose ponezumab for mild‐to‐moderate Alzheimer's disease: Safety and efficacy

DOIFull Paper Access

59

Citations

11

References

2017

Year

Jaren W. Landen, Sharon Cohen, Clare B. Billing, Carol Cronenberger, Scot Styren, Aaron H. Burstein, Catherine Sattler, Jae‐Hong Lee, Clifford R. Jack, Kejal Kantarci,
Alzheimer s & Dementia Translational Research & Clinical Interventions

Abstract

Multiple-dose ponezumab was generally safe, but not efficacious, in mild-to-moderate AD.

References

YearCitations

Page 1